Shin-ichi Hayashi - Search Results

This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Save citations to file

Email citations

Subject: Shin-ichi Hayashi - PubMed

To:

From:

Selection:

Format:

MeSH and other data

Add to Collections

Add to My Bibliography

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Results by year

Year	Number of Results
2002	10
2003	10
2004	5
2005	9
2006	6
2007	10
2008	13
2009	7
2010	3
2011	9
2012	12
2013	8
2014	7
2015	2
2016	7
2017	5
2018	3
2019	7
2020	4
2021	1
2022	3
2023	1
2024	0

118 results

Page of 12

Results by year

Page 1

Resveratrol exhibits diverse anti-cancer activities through epigenetic regulation of E-cadherin and p21 in triple-negative breast cancer cells.

Sakamoto T, Tanimoto K, Eguchi H, Sasaki S, Tsuboi K, Hayashi SI, Ichihara S. Sakamoto T, et al. Among authors: hayashi si. Breast Cancer. 2023 Sep;30(5):727-738. doi: 10.1007/s12282-023-01465-2. Epub 2023 May 11. Breast Cancer. 2023. PMID: 37166625

One DNA Methylation Regulates CHIP Gene Expression of Human Breast Cancer and Predicts Recurrence.

Gohno T, Hanamura T, Kurosumi M, Takei H, Yamaguchi Y, Hayashi SI. Gohno T, et al. Among authors: hayashi si. Anticancer Res. 2022 Feb;42(2):759-766. doi: 10.21873/anticanres.15534. Anticancer Res. 2022. PMID: 35093874

Correction to: Molecular targeted drugs resistance impairs double‑strand break repair and sensitizes ER‑positive breast cancer to PARP inhibitors.

Suzuki Y, Wenwen W, Ohta T, Hayashi SI. Suzuki Y, et al. Among authors: hayashi si. Breast Cancer. 2022 Jan;29(1):185. doi: 10.1007/s12282-021-01288-z. Breast Cancer. 2022. PMID: 34420190 No abstract available.

Molecular targeted drugs resistance impairs double-strand break repair and sensitizes ER-positive breast cancer to PARP inhibitors.

Suzuki Y, Wenwen W, Ohta T, Hayashi SI. Suzuki Y, et al. Among authors: hayashi si. Breast Cancer. 2022 Jan;29(1):77-91. doi: 10.1007/s12282-021-01282-5. Epub 2021 Aug 3. Breast Cancer. 2022. PMID: 34346034

CD4⁺ Resident Memory T Cells Mediate Long-Term Local Skin Immune Memory of Contact Hypersensitivity in BALB/c Mice.

Murata A, Hayashi SI. Murata A, et al. Among authors: hayashi si. Front Immunol. 2020 May 19;11:775. doi: 10.3389/fimmu.2020.00775. eCollection 2020. Front Immunol. 2020. PMID: 32508808 Free PMC article.

Heregulin controls ERα and HER2 signaling in mammospheres of ERα-positive breast cancer cells and interferes with the efficacy of molecular targeted therapy.

Fukui F, Hayashi SI, Yamaguchi Y. Fukui F, et al. Among authors: hayashi si. J Steroid Biochem Mol Biol. 2020 Jul;201:105698. doi: 10.1016/j.jsbmb.2020.105698. Epub 2020 May 11. J Steroid Biochem Mol Biol. 2020. PMID: 32404282

Decreased ER dependency after acquired resistance to CDK4/6 inhibitors.

Iida M, Toyosawa D, Nakamura M, Tsuboi K, Tokuda E, Niwa T, Ishida T, Hayashi SI. Iida M, et al. Among authors: hayashi si. Breast Cancer. 2020 Sep;27(5):963-972. doi: 10.1007/s12282-020-01090-3. Epub 2020 Apr 15. Breast Cancer. 2020. PMID: 32297248

Characterization of a membrane-associated estrogen receptor in breast cancer cells and its contribution to hormone therapy resistance using a novel selective ligand.

Niwa T, Takanobu J, Suzuki K, Sato Y, Yamaguchi Y, Hayashi SI. Niwa T, et al. Among authors: hayashi si. J Steroid Biochem Mol Biol. 2020 Jul;201:105671. doi: 10.1016/j.jsbmb.2020.105671. Epub 2020 Apr 11. J Steroid Biochem Mol Biol. 2020. PMID: 32289430

The p21 levels have the potential to be a monitoring marker for ribociclib in breast cancer.

Iida M, Nakamura M, Tokuda E, Toyosawa D, Niwa T, Ohuchi N, Ishida T, Hayashi SI. Iida M, et al. Among authors: hayashi si. Oncotarget. 2019 Aug 6;10(47):4907-4918. doi: 10.18632/oncotarget.27127. eCollection 2019 Aug 6. Oncotarget. 2019. PMID: 31448056 Free PMC article.

Tumor microenvironmental growth factors induce long-term estrogen deprivation resistance in breast cancer.

Tsuboi K, Uematsu C, Yamaguchi Y, Niwa T, Hayashi SI. Tsuboi K, et al. Among authors: hayashi si. Breast Cancer. 2019 Nov;26(6):748-757. doi: 10.1007/s12282-019-00978-z. Epub 2019 May 22. Breast Cancer. 2019. PMID: 31119683

118 results

Page of 12

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

118 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Results by year